Scienture Holdings, Inc. (NASDAQ:SCNX) Short Interest Down 29.7% in January

Scienture Holdings, Inc. (NASDAQ:SCNX) was the target of a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 2,463,891 shares, a drop of 29.7% from the January 15th total of 3,504,653 shares. Based on an average daily volume of 681,002 shares, the short-interest ratio is currently 3.6 days. Currently, 7.7% of the shares of the company are sold short. Currently, 7.7% of the shares of the company are sold short. Based on an average daily volume of 681,002 shares, the short-interest ratio is currently 3.6 days.

Scienture Stock Performance

Shares of SCNX stock opened at $0.43 on Friday. Scienture has a 52 week low of $0.42 and a 52 week high of $3.61. The company has a market capitalization of $17.59 million, a price-to-earnings ratio of -0.43 and a beta of 3.02. The company has a 50-day simple moving average of $0.52 and a 200 day simple moving average of $0.83.

Scienture (NASDAQ:SCNX) last issued its quarterly earnings data on Wednesday, November 12th. The company reported ($0.19) earnings per share (EPS) for the quarter. The business had revenue of $0.59 million for the quarter.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Scienture in a research note on Monday, December 29th. Wall Street Zen lowered Scienture from a “hold” rating to a “sell” rating in a report on Sunday, January 25th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

Institutional Trading of Scienture

A hedge fund recently raised its stake in Scienture stock. Geode Capital Management LLC boosted its position in Scienture Holdings, Inc. (NASDAQ:SCNX) by 264.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 316,201 shares of the company’s stock after purchasing an additional 229,398 shares during the quarter. Geode Capital Management LLC owned about 0.78% of Scienture worth $161,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 5.68% of the company’s stock.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.